Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured
Published in Dermatology

Journal Scan / Research · February 15, 2017

Adalimumab Is a Safe Option for Patients With Psoriasis and Concomitant HBV or HCV

Journal of the European Academy of Dermatology and Venereology: JEADV

 

Additional Info

Journal of the European Academy of Dermatology and Venereology: JEADV
Adalimumab Is a Safe Option for Psoriasis Patients With Concomitant Hepatitis B or C Infection: A Multicentre Cohort Study of 37 Patients and Review of the Literature
J Eur Acad Dermatol Venereol 2017 Feb 01;[EPub Ahead of Print], S Piaserico, P Dapavo, A Conti, P Gisondi, FP Russo

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading